1-7 of 7 results for SimpleDrops
| Formulation | Classification | Strength |
|---|---|---|
| Brim-Dor® PF (Brimonidine/Dorzolamide)* – 10mL | Topical Medication | 0.15/2% |
| Dorzolamide PF* – 10mL | Topical Medication | 2% |
| Latanoprost PF* – 7.5mL | Topical Medication | 0.005% |
| Tim-Brim-Dor-Lat® (Timolol/Brimonidine/Dorzolamide/Latanoprost) PF* – 5mL | Topical Medication | 0.5/0.15/2/0.005% |
| Tim-Brim-Dor® PF (Timolol/Brimonidine/Dorzolamide)* – 10mL | Topical Medication | 0.5/0.15/2% |
| Tim-Dor-Lat® (Timolol/Dorzolamide/Latanoprost) PF* – 5mL | Topical Medication | 0.5/2/0.005% |
| Tim-Lat® (Timolol/Latanoprost) PF* – 5mL | Topical Medication | 0.5%/0.005% |
Patients may need to take more than one eye drop product pursuant to multiple dosing regimens, as directed by his or her prescriber, in order for the active ingredients to remain effective throughout the day.
*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. ImprimisRx® dispenses only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.
Potential Ingredient Risks
Storage: Store at Room Temperature, 20°C to 25°C (68°F to 77°F)
Auxiliary Labeling: Store upright in original bottle. Protect from light.
Brimonidine Tartrate
Possible Indications: Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma
Possible Adverse Effects: Oral dryness, Ocular hyperemia, Burning and Stinging on Instillation, Headache, Blurred vision, Foreign body sensation, Fatigue/drowsiness, Conjunctival follicles, Ocular allergic reactions, Ocular pruritis, Corneal staining/erosion, Photophobia, Eyelid erythema, Ocular ache/pain, Upper respiratory symptoms, Dizziness, Blepharitis; ocular irritation, Lid crusting, Conjunctival hemorrhaging, Abnormal taste, Insomnia, Depression, Hypertension, Anxiety, Palpitations/arrhythmias, Nasal dryness and syncope
Potential Contraindications/Precautions:
Infants, Lactation, Pregnancy, Concomitant MAO Inhibitor Therapy
Dorzolamide
Possible Indications: Treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma
Possible Adverse Effects: Ocular burning; stinging; or discomfort immediately following ocular administration, Bitter taste, Superficial punctate keratitis, Ocular allergic reaction, Conjunctivitis and lid reactions, Blurred vision, Eye redness, Tearing, Dryness, Photophobia, Headache, Nausea, Asthenia/fatigue, Skin rashes, Urolithiasis, Iridocyclitis
Potential Contraindications/Precautions: Neonates and Patients Less than 12 Years, Lactation, Pregnancy